Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial: study protocol for a randomized controlled trial
暂无分享,去创建一个
C. MacAulay | J. Lee | K. Berean | Donald W. Anderson | C. Poh | M. Rosin | P. Brasher | J. Durham | Penelope M. A. Brasher | Don W. Anderson | J. Lee | J. Durham
[1] C. Garnis,et al. A Dynamic Oral Cancer Field: Unraveling the Underlying Biology and Its Clinical Implication , 2009, The American journal of surgical pathology.
[2] C. MacAulay,et al. Tracing the “At-Risk” Oral Mucosa Field with Autofluorescence: Steps Toward Clinical Impact , 2009, Cancer Prevention Research.
[3] Neil K. Aaronson,et al. Speech Handicap Index in patients with oral and pharyngeal cancer: Better understanding of patients' complaints , 2008, Head & neck.
[4] Steve Scoppa,et al. Multiple Cancer Prevalence: A Growing Challenge in Long-term Survivorship , 2007, Cancer Epidemiology Biomarkers & Prevention.
[5] Pierre Lane,et al. Direct fluorescence visualization of clinically occult high‐risk oral premalignant disease using a simple hand‐held device , 2007, Head & neck.
[6] Calum MacAulay,et al. Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients , 2006, Clinical Cancer Research.
[7] G. Thomas,et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial , 2005, The Lancet.
[8] Stephen Joel Coons,et al. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.
[9] C. R. Leemans,et al. Molecular Diagnosis of Surgical Margins and Local Recurrence in Head and Neck Cancer Patients , 2004, Clinical Cancer Research.
[10] C. R. Leemans,et al. Genetically Altered Fields as Origin of Locally Recurrent Head and Neck Cancer , 2004, Clinical Cancer Research.
[11] C. R. Leemans,et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.
[12] C. R. Leemans,et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[14] N D Le,et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] E. Vokes,et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy‐head and neck scale: A study of utility and validity , 1996, Cancer.
[16] R H Hruban,et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.
[17] G. Snow,et al. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor , 1994, Cancer.
[18] S. Pocock,et al. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.